(no title)
bransonf | 4 years ago
$5.32-8.87 cost of production depending on the insulin analog.
As noted above, I did not account for R&D and manufacturing capacity.
Regardless, I tried to estimate conservatively at a $12-13 per vial overall cost. My napkin math is certainly wrong.
The point is that Walmart still stands to generate a multi-billion dollar per year profit on the sale of this insulin. (Unless my market capture estimate is wrong by an order of 6+, which it could be)
To be clear, I’m not opposed (in fact grateful) that Walmart is competing in the insulin market. However, I still find it unfortunate that we in the United States pay more for Insulin than any other country in the world, even with this competition.
No comments yet.